{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:30:09Z","timestamp":1786116609616,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06154-0","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:25:04Z","timestamp":1780392304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atypical neuroleptic malignant syndrome in a geriatric palliative care patient: a case report and review of the literature"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-2642","authenticated-orcid":false,"given":"Mete","family":"Ucdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evren","family":"Ekingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"12","key":"6154_CR1","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJMra2404606","volume":"391","author":"EFM Wijdicks","year":"2024","unstructured":"Wijdicks EFM, Ropper AH. Neuroleptic malignant syndrome. N Engl J Med. 2024;391(12):1130\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"6154_CR2","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4088\/JCP.v65n0403","volume":"65","author":"J Ananth","year":"2004","unstructured":"Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65(4):464\u201370.","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"6154_CR3","first-page":"1366","volume":"162","author":"MD Andreassen","year":"2000","unstructured":"Andreassen MD, Pedersen S. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS]. Ugeskr Laeger. 2000;162(10):1366\u201370.","journal-title":"Ugeskr Laeger"},{"issue":"11","key":"6154_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1177\/1060028016657553","volume":"50","author":"DJ Pileggi","year":"2016","unstructured":"Pileggi DJ, Cook AM. Neuroleptic malignant syndrome. Ann Pharmacother. 2016;50(11):973\u201381.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"6154_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","volume":"77","author":"SN Caroff","year":"1993","unstructured":"Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77(1):185\u2013202.","journal-title":"Med Clin North Am"},{"issue":"24","key":"6154_CR6","doi-asserted-by":"publisher","first-page":"8901","DOI":"10.3390\/jcm14248901","volume":"14","author":"P Pewloungsawat","year":"2025","unstructured":"Pewloungsawat P, Srisuma S, Ruangritchankul S. Clinical outcomes and factors associated with neuroleptic malignant syndrome in older patients: a case control study. J Clin Med. 2025;14(24):8901.","journal-title":"J Clin Med"},{"issue":"1","key":"6154_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/NI.Neurol-India-D-23-00303","volume":"73","author":"MS Sen","year":"2025","unstructured":"Sen MS, Kushwaha S, Dhamija RK, Singh M, Dung Dung AA, Kumar PA, et al. Neuroleptic malignant syndrome: a retrospective chart review from a tertiary neuropsychiatric facility. Neurol India. 2025;73(1):117\u201322.","journal-title":"Neurol India"},{"issue":"2","key":"6154_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/14737175.2024.2417414","volume":"25","author":"L Orsolini","year":"2025","unstructured":"Orsolini L, Volpe U. Expert guidance on the differential diagnosis of neuroleptic malignant syndrome. Expert Rev Neurother. 2025;25(2):125\u201332.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"6154_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/JCP.0000000000000640","volume":"37","author":"RJ Gurrera","year":"2017","unstructured":"Gurrera RJ, Mortillaro G, Velamoor V, Caroff SN. A validation study of the International Consensus Diagnostic Criteria for neuroleptic malignant syndrome. J Clin Psychopharmacol. 2017;37(1):67\u201371.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"6154_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.30773\/pi.2017.06.05","volume":"15","author":"\u0130 \u00d6zdemir","year":"2018","unstructured":"\u00d6zdemir \u0130, Kuru E, Safak Y, Tulac\u0131 RG. A neuroleptic malignant syndrome without rigidity. Psychiatry Investig. 2018;15(2):226\u20139.","journal-title":"Psychiatry Investig"},{"key":"6154_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214901","author":"A Collins","year":"2016","unstructured":"Collins A, Davies D, Menon S. Atypical neuroleptic malignant syndrome. BMJ Case Rep. 2016. https:\/\/doi.org\/10.1136\/bcr-2016-214901.","journal-title":"BMJ Case Rep"},{"issue":"5","key":"6154_CR12","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.5811\/WESTJEM.41514","volume":"26","author":"A Chen","year":"2025","unstructured":"Chen A, Bae M. Lorazepam in managing atypical neuroleptic malignant syndrome: a systematic review of case reports. West J Emerg Med. 2025;26(5):1446\u201353.","journal-title":"West J Emerg Med"},{"issue":"7","key":"6154_CR13","first-page":"e63784","volume":"16","author":"T Kutumbaka","year":"2024","unstructured":"Kutumbaka T, Varadan S, Sudagar Singh RB. The atypical face of neuroleptic malignant syndrome: a case report of ileus and absent rigidity. Cureus. 2024;16(7):e63784.","journal-title":"Cureus"},{"issue":"7-8","key":"6154_CR14","first-page":"20","volume":"15","author":"DCL Teo","year":"2018","unstructured":"Teo DCL, Wong HK, Tan SN. Atypical neuroleptic malignant syndrome precipitated by Clozapine and Quetiapine overdose: a diagnostic challenge. Innov Clin Neurosci. 2018;15(7\u20138):20\u20132.","journal-title":"Innov Clin Neurosci"},{"issue":"1","key":"6154_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/1941875210386491","volume":"1","author":"BD Berman","year":"2011","unstructured":"Berman BD. Neuroleptic malignant syndrome: a review for neurohospitalists. Neurohospitalist. 2011;1(1):41\u20137.","journal-title":"Neurohospitalist"},{"issue":"1","key":"6154_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40268-014-0078-0","volume":"15","author":"M Belvederi Murri","year":"2015","unstructured":"Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015;15(1):45\u201362.","journal-title":"Drugs R D"},{"key":"6154_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1560248","author":"Z-k Fan","year":"2025","unstructured":"Fan Z-k, Yi R-q, Zhang Z-r, Shen Y-y. Case report: neuroleptic malignant syndrome in a 15-year-old female following of psychotropic drugs. Front Psychiatry. 2025. https:\/\/doi.org\/10.3389\/fpsyt.2025.1560248.","journal-title":"Front Psychiatry"},{"issue":"2","key":"6154_CR18","first-page":"166","volume":"58","author":"E Ero\u011flu","year":"2021","unstructured":"Ero\u011flu E, Yildiz M, Yazici MK. Atypical neuroleptic malignant syndrome induced by low dose Quetiapine in a patient treated with Donepezil. Noro Psikiyatr Ars. 2021;58(2):166\u20138.","journal-title":"Noro Psikiyatr Ars"},{"issue":"1","key":"6154_CR19","first-page":"e12602","volume":"13","author":"SD Hernandez","year":"2021","unstructured":"Hernandez SD, Marotta DA, Goteti R. Atypical neuroleptic malignant syndrome in the setting of Quetiapine overdose: a case report and review of the literature. Cureus. 2021;13(1):e12602.","journal-title":"Cureus"},{"issue":"9","key":"6154_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/070674379504000907","volume":"40","author":"VR Velamoor","year":"1995","unstructured":"Velamoor VR, Swamy GN, Parmar RS, Williamson P, Caroff SN. Management of suspected neuroleptic malignant syndrome. Can J Psychiatry. 1995;40(9):545\u201350.","journal-title":"Can J Psychiatry"},{"key":"6154_CR21","doi-asserted-by":"publisher","first-page":"232470962412626","DOI":"10.1177\/23247096241262690","volume":"12","author":"J Allonce","year":"2024","unstructured":"Allonce J, Khan S, Pulford B. Atypical presentation of Ziprasidone-induced neuroleptic malignant syndrome: a case report. J Investig Med High Impact Case Rep. 2024;12:23247096241262690.","journal-title":"J Investig Med High Impact Case Rep"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06154-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06154-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:03:37Z","timestamp":1786014217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06154-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6154"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06154-0","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was not required for this single case report, in accordance with the institutional policy of Etimesgut \u015eehit Sait Ert\u00fcrk State Hospital. Written informed consent was obtained from the patient for the use of his clinical information in this report.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"441"}}